title: [Ewing sarcoma and pregnancy].
authors.forename: J
authors.initials: J
authors.lastname: Feliu
authors.forename: J A
authors.initials: JA
authors.lastname: López Mondéjar
authors.forename: B
authors.initials: B
authors.lastname: Martínez
authors.forename: M L
authors.initials: ML
authors.lastname: García Paredes
authors.forename: I
authors.initials: I
authors.lastname: Cebreiros
authors.forename: J M
authors.initials: JM
authors.lastname: Montero
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003025:Clubfoot / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006228:Hand Deformities, Congenital; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D013125:Spinal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide
vernacular_title: Sarcoma de Ewing y gestación.